In patients with systemic sclerosis, Tim-1+ B cells lost the ability to inhibit autologous CD4+ T cell responses, including the proliferation of CD4+ T cells and the production of IFN-γ, TNF-α, and IL-17 (104). The gene discussed is CD4; the disease is systemic sclerosis.